ASTRONAUTX LIMITED

Active Altrincham

Research and experimental development on biotechnology

4 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
A

ASTRONAUTX LIMITED

Research and experimental development on biotechnology

Founded 1 Apr 2019 Active Altrincham, United Kingdom 4 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 18 Jul 2025 Next due 30 Sept 2026 5 months remaining
Confirmation Submitted 10 Apr 2026 Next due 14 Apr 2027 12 months remaining
Net assets £-2M £5M 2023 year on year
Total assets £6M £3M 2023 year on year
Total Liabilities £7M £2M 2023 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

3rd Floor 1 Ashley Road Altrincham Cheshire WA14 2DT United Kingdom

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for ASTRONAUTX LIMITED (11919384), an active life sciences and medical technology company based in Altrincham, United Kingdom. Incorporated 1 Apr 2019. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2023
Type Total Exemption Full
Next accounts 31 December 2024
Due by 30 September 2025 9 months

Net Assets, Total Assets & Total Liabilities (2019–2023)

Cash in Bank

£4.56M

Increased by £2.97M (+186%)

Net Assets

-£1.58M

Increased by £5.21M (+77%)

Total Liabilities

£7.08M

Decreased by £1.81M (-20%)

Turnover

£649.55k

Employees

4

Increased by 1 (+33%)

Debt Ratio

129%

Decreased by 294 (-70%)

Financial History

Revenue, profit, EBITDA and key financial figures

2023
Dec Year End
2022
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 3

Investors (8)

Investor NameInvestor SinceParticipating Rounds
Investor 1Apr 2019Seed, Series A
Investor 2Apr 2019Seed
Investor 8Mar 2020Seed

Share Capital

Share Capital

Share allotments and capital structure

13 Allotments 62,386,905 Shares £58.34m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
27 Jan 202618,000,000£18.00m£1
15 Dec 2025545,818£54.582£0
21 Nov 202569,977£6.998£0
22 Jul 2025130,970£13.097£0
20 Dec 202418,000,000£18.00m£1

Officers

Officers

2 active 1 resigned
Status
Barker, Laurence Daniel PaulDirectorBritishUnited Kingdom5325 Mar 2020Active
Rhodes, Jane Kathleen ReltonDirectorAmericanUnited States583 Sept 2024Active

Shareholders

Shareholders (37)

Novartis Bioventures Ltd
14.3%
6,250,000
Mpm Bioventures 2022, Lp
14.3%
6,250,000

Persons with Significant Control

Persons with Significant Control (0)

0 Active 4 Ceased

Dementia Discovery Gp Lp

Ceased 20 Dec 2024

Ceased

Sv Health Managers Llp

Ceased 12 Jul 2024

Ceased

David Reynolds

Ceased 2 Mar 2020

Ceased

Ruth Mckernan

Ceased 2 Mar 2020

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
10 Apr 2026Confirmation StatementConfirmation statement made on 2026-03-31 with updates
17 Feb 2026CapitalAllotment of shares (GBP 6,260.6176) on 2026-01-27
15 Dec 2025CapitalAllotment of shares (GBP 4,460.6176) on 2025-12-15
11 Dec 2025CapitalAllotment of shares (GBP 4,406.0358) on 2025-11-21
11 Dec 2025CapitalAllotment of shares (GBP 4,399.0381) on 2025-07-22
10 Apr 2026 Confirmation Statement

Confirmation statement made on 2026-03-31 with updates

17 Feb 2026 Capital

Allotment of shares (GBP 6,260.6176) on 2026-01-27

15 Dec 2025 Capital

Allotment of shares (GBP 4,460.6176) on 2025-12-15

11 Dec 2025 Capital

Allotment of shares (GBP 4,406.0358) on 2025-11-21

11 Dec 2025 Capital

Allotment of shares (GBP 4,399.0381) on 2025-07-22

Recent Activity

Latest Activity

Confirmation statement made on 2026-03-31 with updates

1 weeks ago on 10 Apr 2026

Allotment of shares (GBP 6,260.6176) on 2026-01-27

1 months ago on 17 Feb 2026

Allotment of shares (GBP 4,460.6176) on 2025-12-15

4 months ago on 15 Dec 2025

Allotment of shares (GBP 4,406.0358) on 2025-11-21

4 months ago on 11 Dec 2025

Allotment of shares (GBP 4,399.0381) on 2025-07-22

4 months ago on 11 Dec 2025